Vancouver, British Columbia and Toronto, Ontario--(Newsfile Corp. - October 1, 2024) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024, in Toronto Ontario. Hamed Shahbazi, Founder and CEO of WELL will be doing an investor presentation and participating in 1-on-1 meetings with investors at the conference. Mr. Shahbazi will also be participating on a panel titled "Growth Through Acquisition in the Canadian Capital Markets" at 12:30pm.
2024 Cantech Letter Conference
Date: Wednesday, October 9, 2024
Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. to register
More info: https://www.cantechletter.com/conference/
About Cantech Letter Conference
The Cantech Letter Conference, recognized as Canada's foremost technology investment event, provides up and coming technology companies with the unique opportunity to showcase their innovations and growth strategies, and participate in individual 1-on-1 meetings with potential investors and capital markets professionals. The conference serves as a hub for networking, knowledge exchange, and investment opportunities, while also featuring panel discussions with industry experts to offer insights into current trends, challenges, and opportunities within the technology sector.
About WELL Health Technologies Corp.
WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 37,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 180 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more about WELL, please visit: www.well.company.
For additional Information:
Tyler Baba
Investor Relations, Manager
WELL Health Technologies
This email address is being protected from spambots. You need JavaScript enabled to view it.
604-628-7266
| Last Trade: | C$7.00 |
| Daily Change: | -0.09 -1.27 |
| Daily Volume: | 1,958,396 |
| Market Cap: | C$1.740B |
October 09, 2024 September 10, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
